SITE MAP  |  TERMS OF USE  |  © 2010 RHYTHM PHARMACEUTICALS
Overview
Management
Board of Directors
Scientific Advisory Board
Investors
INVESTORS
Rhythm has raised $40 million in a Series A equity financing. Investors include MPM Capital, New Enterprise Associates, and Third Rock Ventures.


  •   ABOUT RHYTHM  
    • Corporate Overview
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Investors
  •   PROGRAMS  
    • Technology: Peptide Therapeutics
    • Focus
    •        Obesity & Diabetes
    •        GI Functional Disorders
    • Pipeline
    •        Ghrelin: RM-131
    •        MC4: RM-493
  •   NEWS & RESOURCES  
    • Press Releases
  •   CONTACT
    • Contact Rhythm
    • Directions